Search result for 'chronic kidney disease'

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India under the brand name Empanorm, offering prices 80% lower than innovator...

Nephrocare India highlights the importance of preventive renal care to combat the growing kidney disease burden in India. The company emphasizes a healthy lifestyle, including regular exercise and...

Zydus Lifesciences and CSIR-CDRI have partnered to develop a new drug for chronic kidney disease-induced osteoporosis, targeting Sclerostin inhibition. The collaboration aims to bring affordable...

Sun Pharma has partnered with Bayer to market Finerenone, a drug for chronic kidney disease associated with type 2 diabetes mellitus, in India.

Nephrocare India, a Kolkata-based renal care institution, secures Rs 8.08 crore in pre-IPO funding to expand its network of kidney care facilities across India.

Nephrocare India plans to establish 22 kidney care centers across India by March 2026, aiming to reach 1 million CKD patients in the next decade. The company is exploring fundraising options,...